Loading...
此记录已被删除。由于它已链接到已发布的记录,因此此处仅供参考。
单击此处查看已删除的记录本文档已更新。这不是最新发布的版本。 单击此处查看该记录的最新版本。
改性活生物体
(LMO)
Proteqflu - equine influenza vaccine
EN
Strains vCP2242 and vCP1533
否
-
,组织:Merial ()私营部门(工商业)
, 法国电话号码: +33 472 72 3000,传真:电子邮箱地址:网站: http://fr.merial.com,
"Proteqflu" is a vaccine made from recombinant canary pox virus modified with haemagglutinin gene from Equine Influenza. This LMO is used to vaccinate horses against Equine Influenza.
After inoculation, the viruses do not multiply in the horse but express the protective proteins. As a consequence, these components induce immunity against equine influenza virus (H3N8).
EN
After inoculation, the viruses do not multiply in the horse but express the protective proteins. As a consequence, these components induce immunity against equine influenza virus (H3N8).
“受体生物体”一词是指经受基因改性的生物体(已改性或未改性),而“亲本生物体”是指那些参与交叉育种或细胞融合的生物体。
-
BCH-ORGA-SCBD-45008-6 生物体 Canarypox virus (CNPV)病毒
ZH
pJT006
EN
- 其他 (Homologous Recombination)
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
其中部分基因片段,可能以片段或片段或截短形态存在。请参见下面的说明(如适用)。
-
BCH-GENE-SCBD-45883-4 Hemagglutinin gene | Influenza A virus (Influenza, Flu, Avian flu, Human flu, Swine influenza, Equine influenza, Bird flu)蛋白质编码序列 | 医疗或药物化合物的生产(人或动物) (疫苗)
-
BCH-GENE-SCBD-103890-2 H6 Gene Promoter | Vaccinia virus (Poxvirus, Smallpox vaccine, VACV, VV, Vaccinia)启动子
-
BCH-GENE-SCBD-103891-1 C5 right flanking arm | Canarypox virus (CNPV)Plasmid Vector
-
BCH-GENE-SCBD-103892-1 C5 left flanking arm | Canarypox virus (CNPV)Plasmid Vector
The following strains of Influenza viruses were used as donor organisms:
Influenza A/equine-2/Ohio/03[H3N8]Canarypox virus (vCP2242 - American strain)and Influenza A/equi-2/Newmarket/2/93 [H3N8] recombinant Canarypox virus (vCP1533 - European strain).
EN
Influenza A/equine-2/Ohio/03[H3N8]Canarypox virus (vCP2242 - American strain)and Influenza A/equi-2/Newmarket/2/93 [H3N8] recombinant Canarypox virus (vCP1533 - European strain).
ZH
- 疫苗
ZH
ZH
| 记录类型 | 字段 | 记录 | |
|---|---|---|---|
| 各国的决定或其它通讯往来 | 改性活生物体识别 | 4 | |
| 根据规定方式作出的风险评估 | 改性活生物体 | 3 | |
| 改性活生物体 | 相关改性活生物体 | 1 | |